The current status of phototherapy in multimodal anti-cancer nanomedicines

Photodiagnosis Photodyn Ther. 2019 Jun:26:350. doi: 10.1016/j.pdpdt.2019.04.024. Epub 2019 Apr 28.

Authors

M Ibrahim Khot¹, Gemma Armstrong², Helen Andrew², Candice L Downey², David G Jayne²

Affiliations

¹ School of Medicine, St James's University Hospital, University of Leeds, Leeds, UK. Electronic address: [email protected].
² School of Medicine, St James's University Hospital, University of Leeds, Leeds, UK.

PMID: 31042555
DOI: 10.1016/j.pdpdt.2019.04.024

No abstract available

Publication types

Letter

MeSH terms

Antineoplastic Agents / administration & dosage
Antineoplastic Agents / pharmacology
Antineoplastic Agents / therapeutic use*
Carboplatin / administration & dosage
Carboplatin / pharmacology
Carboplatin / therapeutic use*
Drug Therapy, Combination
Humans
Hydrogen-Ion Concentration
Indocyanine Green / administration & dosage
Indocyanine Green / pharmacology
Indocyanine Green / therapeutic use*
MCF-7 Cells
Nanoparticles
Neoplasms / drug therapy*
Photochemotherapy / methods*
Photosensitizing Agents / administration & dosage
Photosensitizing Agents / pharmacology
Photosensitizing Agents / therapeutic use*

Substances

Antineoplastic Agents
Photosensitizing Agents
Carboplatin
Indocyanine Green